SOPHiA GENETICS S.A.
SOPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $202,810 | $304,977 | $132,044 | $900,392 |
| - Cash | $80,226 | $123,251 | $161,305 | $192,962 |
| + Debt | $30,030 | $18,601 | $16,743 | $13,059 |
| Enterprise Value | $152,614 | $200,327 | -$12,518 | $720,489 |
| Revenue | $65,173 | $62,371 | $47,560 | $40,450 |
| % Growth | 4.5% | 31.1% | 17.6% | – |
| Gross Profit | $43,937 | $42,913 | $31,254 | $25,221 |
| % Margin | 67.4% | 68.8% | 65.7% | 62.4% |
| EBITDA | -$50,761 | -$69,571 | -$81,375 | -$69,240 |
| % Margin | -77.9% | -111.5% | -171.1% | -171.2% |
| Net Income | -$62,493 | -$78,981 | -$87,449 | -$73,675 |
| % Margin | -95.9% | -126.6% | -183.9% | -182.1% |
| EPS Diluted | -0.95 | -1.22 | -1.36 | -1.33 |
| % Growth | 22.1% | 10.3% | -2.3% | – |
| Operating Cash Flow | -$42,822 | -$48,575 | -$70,093 | -$57,939 |
| Capital Expenditures | -$8,176 | -$9,226 | -$10,381 | -$6,671 |
| Free Cash Flow | -$50,998 | -$57,801 | -$80,474 | -$64,610 |